Advanced search
Publication Cover
Acta Oto-Laryngologica Volume 138, 2018 - Issue 12
Submit an article Journal homepage
144
Views
2
CrossRef citations to date
0
Altmetric
Articles

Rational choice of induction chemotherapy-based larynx preservation for hypopharyngeal cancer

Shuzhou LiuOtorhinolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Beijing, China; ;Otorhinolaryngology Head and Neck Surgery, Hainan General Hospital, Haikou, ChinaORCID Iconhttp://orcid.org/0000-0003-4874-8571View further author information
ORCID Icon,
Jugao FangOtorhinolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Beijing, China; ;Key Laboratory of Otorhinolaryngology Head and Neck Surgery, Ministry of Education, Beijing Institute of Otorhinolaryngology, Beijing, China; Correspondence[email protected]
View further author information
,
Hongzhi MaOtorhinolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Beijing, China; View further author information
,
Lingzhao MengOtolaryngology Head and Neck Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, China; View further author information
,
Yunfei BaiOtorhinolaryngology Head and Neck Surgery, Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China; View further author information
,
Ling FengOtorhinolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Beijing, China; View further author information
,
Meng LianOtorhinolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Beijing, China; View further author information
,
Pingdong LiOtorhinolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Beijing, China; View further author information
,
Qi ZhongOtorhinolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Beijing, China; View further author information
&
Lizhen HouOtorhinolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Beijing, China; View further author information
 show all
Pages 1146-1153 | Received 22 May 2018, Accepted 25 Jul 2018, Published online: 21 Jan 2019

References

  • Hoffman HT, Karnell LH, Funk GF, et al. The National Cancer Data Base report on cancer of the head and neck. Arch Otolaryngol Head Neck Surg. 1998;124:951–962. SepPubMed PMID: 9738803.
  • Cooper JS, Porter K, Mallin K, et al. National Cancer Database report on cancer of the head and neck: 10-year update. Head Neck. 2009;31:748–758. Jun doi: 10.1002/hed.21022.
  • Kuo P, Chen MM, Decker RH, et al. Hypopharyngeal cancer incidence, treatment, and survival: temporal trends in the United States. Laryngoscope. 2014;124:2064–2069. SepPubMed PMID: 25295351.
  • Department of Veterans Affairs Laryngeal Cancer Study Group, Wolf GT, Fisher SG, et al. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med. 1991;324:1685–1690. Jun 13 doi: 10.1056/NEJM199106133242402.
  • Lefebvre JL, Chevalier D, Luboinski B, et al. Larynx preservation in pyriform sinus cancer: preliminary results of a European organization for research and treatment of cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst. 1996;88:890–899. Jul 03PubMed PMID: 8656441.
  • Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349:2091–2098. Nov 27 doi: 10.1056/NEJMoa031317.
  • Posner MR, Hershock DM, Blajman CR, et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med. 2007;357:1705–1715. Oct 25 doi: 10.1056/NEJMoa070956.
  • Takes RP, Strojan P, Silver CE, et al. Current trends in initial management of hypopharyngeal cancer: the declining use of open surgery. Head Neck. 2012;34:270–281. Feb doi: 10.1002/hed.21613.
  • Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228–247. Jan doi: 10.1016/j.ejca.2008.10.026.
  • Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341–1346. Mar 30 doi: 10.1016/0360-3016(95)00060-C.
  • Pignon JP, le Maitre A, Maillard E, et al. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol. 2009;92:4–14. Jul doi: 10.1016/j.radonc.2009.04.014.
  • Argiris A, Karamouzis MV, Raben D, et al. Head and neck cancer. Lancet 2008;371:1695. May 17709. doi: 10.1016/S0140-6736(08)60728-X.
  • Forastiere AA, Adelstein DJ, Manola J. Induction chemotherapy meta-analysis in head and neck cancer: right answer, wrong question. Jco. 2013;31:2844–2846. Aug 10 doi: 10.1200/JCO.2013.50.3136.
  • Denaro N, Russi EG, Lefebvre JL, et al. A systematic review of current and emerging approaches in the field of larynx preservation. Radiother Oncol. 2014;110:16–24. Jan doi: 10.1016/j.radonc.2013.08.016.
  • Pointreau Y, Garaud P, Chapet S, et al. Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation. J Natl Cancer Inst. 2009;101:498–506. doi: 10.1093/jnci/djp007.
  • Posner MR, Norris CM, Wirth LJ, et al. Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservation. Ann Oncol. 2009;20:921–927. May doi: 10.1093/annonc/mdn752.
  • Hitt R, Lopez-Pousa A, Martinez-Trufero J, et al. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer. Jco. 2005;23:8636–8645. Dec 01 doi: 10.1200/JCO.2004.00.1990.
  • Lefebvre JL, Pointreau Y, Rolland F, et al. Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II study. Jco. 2013;31:853–859. Mar 01 doi: 10.1200/JCO.2012.42.3988.
  • Lefebvre JL, Rolland F, Tesselaar M, et al. Phase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy. J Natl Cancer Inst. 2009;101:142–152. Feb 04 doi: 10.1093/jnci/djn460. PubMed PMID: 19176454; PubMed Central PMCID: PMCPMC2724854.
  • Sun Y, Li WF, Chen NY, et al. Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial. Lancet Oncol. 2016;17:1509–1520. Nov doi: 10.1016/S1470-2045(16)30410-7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.